2012 | Aarkstore.com | Immune Pharmaceuticals Ltd – Product Pipeline by ksbrose86


									You can also request for sample page of above
mention reports on sample@aarkstore.com
Pages : 29

PDF - $ 1500 | Site Licence - $ 3000 | Enterprise License - $
4500 |

Global Market Direct’s pharmaceuticals report, “Immune Pharmaceuticals Ltd -
Product Pipeline Review - 2012” provides data on the Immune Pharmaceuticals
Ltd’s research and development focus. The report includes information on
current developmental pipeline, complete with latest updates, and features on
discontinued and dormant projects.

This report is built using data and information sourced from Global Markets
Direct’s proprietary databases, Immune Pharmaceuticals Ltd’s corporate
website, SEC filings, investor presentations and featured press releases, both
from Immune Pharmaceuticals Ltd and industry-specific third party sources,
put together by Global Markets Direct’s team.

- Immune Pharmaceuticals Ltd - Brief Immune Pharmaceuticals Ltd overview
including business description, key information and facts, and its locations and
- Review of current pipeline of Immune Pharmaceuticals Ltd human therapeutic
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.

Reasons to buy

- Evaluate Immune Pharmaceuticals Ltd’s strategic position with total access to
detailed information on its product pipeline.
- Assess the growth potential of Immune Pharmaceuticals Ltd in its therapy areas of
- Identify new drug targets and therapeutic classes in the Immune Pharmaceuticals
Ltd’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those
- Exploit in-licensing opportunities by identifying windows of opportunity to fill
portfolio gaps.
Table of Contents :

List of Tables 4
List of Figures 4
Immune Pharmaceuticals Ltd Snapshot 5
Immune Pharmaceuticals Ltd Overview 5
Key Information 5
Key Facts 5
Immune Pharmaceuticals Ltd – Research and Development Overview 6
Key Therapeutic Areas 6
Immune Pharmaceuticals Ltd – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Pipeline Products – Combination Treatment Modalities 10
Immune Pharmaceuticals Ltd – Pipeline Products Glance 11
Immune Pharmaceuticals Ltd Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
Immune Pharmaceuticals Ltd – Early Stage Pipeline Products 12
Pre-Clinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Immune Pharmaceuticals Ltd – Drug Profiles 14
Anti Ferritin Gemcitabine Paclitaxel Prodrugs 14
Product Description 14…………….
Please follow link if you want More Related
Reports :

Product Pipeline Review – 2012

Pipeline Review&PubId=&pagenum=1
Related Reports:

Watson Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Zenyaku Kogyo Co., Ltd. – Product Pipeline Review – 2012
Immtech Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Immunovaccine, Inc. – Product Pipeline Review – 2012
Salix Pharmaceuticals, Inc. – Product Pipeline Review – 2012
GlaxoSmithKline Inc. – Product Pipeline Review – 2012
Bristol-Myers Squibb Company – Product Pipeline Review – 2012
F. Hoffmann-La Roche Ltd. – Product Pipeline Review – 2012
Merck & Co., Inc. – Product Pipeline Review – 2012
Pfizer Inc. – Product Pipeline Review – 2012
Amgen Inc. – Product Pipeline Review – 2012
Genentech, Inc. – Product Pipeline Review – 2012
Abbott Laboratories – Product Pipeline Review – 2012
Piramal Healthcare Limited – Product Pipeline Review – 2012
Apricus Biosciences, Inc. – Product Pipeline Review – 2012
Pluristem Therapeutics Inc. – Product Pipeline Review – 2012
Pierre Fabre Dermatologie – Product Pipeline Review – 2012
For More details about above & other
Reports plz contact :


Contact: Marketing team Mob.No.918149852585
Email: enquiry@aarkstore.com ,
URL: http://www.aarkstore.com

To top